SG11201507188QA - Use of benzoic acid salt in the manufacture of a composition for preventing or treating dementia or mild cognitive impairment - Google Patents
Use of benzoic acid salt in the manufacture of a composition for preventing or treating dementia or mild cognitive impairmentInfo
- Publication number
- SG11201507188QA SG11201507188QA SG11201507188QA SG11201507188QA SG11201507188QA SG 11201507188Q A SG11201507188Q A SG 11201507188QA SG 11201507188Q A SG11201507188Q A SG 11201507188QA SG 11201507188Q A SG11201507188Q A SG 11201507188QA SG 11201507188Q A SG11201507188Q A SG 11201507188QA
- Authority
- SG
- Singapore
- Prior art keywords
- manufacture
- preventing
- composition
- benzoic acid
- acid salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SG2014/000140 WO2015147742A1 (en) | 2014-03-24 | 2014-03-24 | Use of benzoic acid salt in the manufactue of a composition for preventing or treating dementia or mild cognitive impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507188QA true SG11201507188QA (en) | 2015-10-29 |
Family
ID=54196083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507188QA SG11201507188QA (en) | 2014-03-24 | 2014-03-24 | Use of benzoic acid salt in the manufacture of a composition for preventing or treating dementia or mild cognitive impairment |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2016517866A (en) |
| KR (2) | KR20160029837A (en) |
| AU (1) | AU2014386718B8 (en) |
| CA (1) | CA2902498C (en) |
| DE (1) | DE212014000063U1 (en) |
| SG (1) | SG11201507188QA (en) |
| WO (1) | WO2015147742A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3027300C (en) * | 2016-06-13 | 2023-08-08 | Syneurx International (Taiwan) Corp. | Co-crystals of lithium benzoate and uses thereof |
| JP6958922B2 (en) * | 2016-06-13 | 2021-11-02 | シニュークス インターナショナル（タイワン）コーポレイション | Co-crystal of sodium benzoate and its use |
| US10336679B2 (en) * | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| AU2018227291B2 (en) * | 2017-03-03 | 2021-02-11 | Excelsior Pharmatech Labs | Method for preventing or treating autism spectrum disorders by benzoic acid salt |
| TW202206061A (en) * | 2017-11-22 | 2022-02-16 | 林潔欣 | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
| JP2007534657A (en) * | 2003-12-29 | 2007-11-29 | セプラコア インコーポレーテッド | Benzo [d] isoxazole inhibitor |
| ES2731228T3 (en) * | 2009-01-20 | 2019-11-14 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Benzoic acid or salts thereof to improve the activity of a pharmaceutical product |
| GB201111704D0 (en) * | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| JP6169492B2 (en) * | 2011-11-15 | 2017-07-26 | 武田薬品工業株式会社 | Dihydroxy aromatic heterocyclic compounds |
-
2014
- 2014-03-24 AU AU2014386718A patent/AU2014386718B8/en active Active
- 2014-03-24 DE DE212014000063.7U patent/DE212014000063U1/en not_active Expired - Lifetime
- 2014-03-24 JP JP2016510654A patent/JP2016517866A/en active Pending
- 2014-03-24 WO PCT/SG2014/000140 patent/WO2015147742A1/en active Application Filing
- 2014-03-24 CA CA2902498A patent/CA2902498C/en active Active
- 2014-03-24 SG SG11201507188QA patent/SG11201507188QA/en unknown
- 2014-03-24 KR KR1020167003184A patent/KR20160029837A/en not_active Application Discontinuation
- 2014-03-24 KR KR1020177024853A patent/KR102162073B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014386718A8 (en) | 2017-12-07 |
| JP2016517866A (en) | 2016-06-20 |
| CA2902498F (en) | 2015-09-24 |
| AU2014386718A1 (en) | 2015-10-08 |
| DE212014000063U1 (en) | 2015-10-12 |
| KR102162073B1 (en) | 2020-10-07 |
| CA2902498A1 (en) | 2015-09-24 |
| KR20170104658A (en) | 2017-09-15 |
| KR20160029837A (en) | 2016-03-15 |
| WO2015147742A1 (en) | 2015-10-01 |
| AU2014386718B2 (en) | 2017-07-20 |
| CA2902498C (en) | 2017-03-28 |
| AU2014386718B8 (en) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE051476T2 (en) | Use of cannabidiolic acid in the treatment of epilepsy | |
| HK1246776A1 (en) | Isoquinoline compounds for the treatment of hiv | |
| SG11201708027XA (en) | Compounds and their use as bace1 inhibitors | |
| HUE051654T2 (en) | Composition for the treatment of acne | |
| HK1258276A1 (en) | Compounds and combinations for the treatment of hiv | |
| SG11201507188QA (en) | Use of benzoic acid salt in the manufacture of a composition for preventing or treating dementia or mild cognitive impairment | |
| PT3481819T (en) | Compounds and their use for reducing uric acid levels | |
| AP2016009497A0 (en) | Process for the treatment of high sulphate waters | |
| HK1232145A1 (en) | Bifunctional compounds and use for reducing uric acid levels | |
| ZA201702377B (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
| HK1232128A1 (en) | Pharmaceutical composition for preventing or treating skin rash | |
| IL252493B (en) | Compounds for use in the prevention or treatment of cancer | |
| IL251407A0 (en) | Multivalent compounds for use in the treatment and prevention of brain damage | |
| GB201501593D0 (en) | New compounds and processes | |
| IL259383A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases | |
| IL251421A0 (en) | Use of neridronic acid or of its salt for the treatment of osteoarthrosis | |
| PL2975004T3 (en) | Acid wastewater treatment | |
| PT3524255T (en) | Composition for the treatment of acne | |
| TH1601002841A (en) | The use of benzoic acid salts in the production of compositions for the prevention or therapy of dementia. or a slight loss of brain ability | |
| GB201518489D0 (en) | Methods for the treatment and prevention of ebola | |
| GB201516922D0 (en) | New processes and compounds | |
| GB201415876D0 (en) | Methods for the treatment and prevention of Ebola |